Nuclear Radiology: Page 18

FDG-PET helps forecast outcome in neuroendocrine tumors
By Wayne Forrest
FDG-PET/CT can be used to classify neuroendocrine tumor patients into different prognostic categories for peptide receptor radionuclide therapy, German researchers have found. The decision to perform FDG-PET/CT should be based on the grading, time course of the disease, speed of progression, total tumor mass, and other criteria, they say.
March 19, 2020
2019 12 13 19 51 1879 Carcinoid Neuroendocrine Tumor 400
RLG issues statement on transporting radiopharmaceuticals
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Radio Pharma Logistics Group (RLG) has pledged to continue to transport radiopharmaceuticals for its national and international clients, despite the substantial challenges posed by the novel coronavirus outbreak.
March 17, 2020
PET tracks down causes of fever in children
By Tami Freeman, PhD
In children with fever of unknown origin, imaging studies are scarce and the usefulness of FDG-PET/CT remains uncertain. Now a Dutch team has examined a large group of children in an attempt to fill the knowledge void.
March 12, 2020
2020 03 12 18 48 4411 2020 03 13 Pet Fever 20200312182919
Eckert & Ziegler begins production of lutetium-177
By AuntMinnieEurope.com staff writers
Isotope technology developer Eckert & Ziegler said it has begun commercial production of carrier-free lutetium-177.
March 10, 2020
European groups sponsor hybrid imaging fellowship
By AuntMinnieEurope.com staff writers
The European School of Radiology (ESOR) and the European Society for Hybrid, Molecular and Translational Imaging (ESHIMT) are receiving applications for its hybrid imaging fellowship program.
March 8, 2020
2020 03 09 20 45 0805 Pet Ct Machine 400
Framatome, Kinectrics partner on Lu-177
By AuntMinnieEurope.com staff writers
French nuclear reactor firm Framatome and Toronto-based Kinectrics have launched a joint venture, called Isogen, to provide support for the production of the medical isotope lutetium-177 (Lu-177).
March 4, 2020
2020 01 08 19 05 8090 Business Hands 400
Eckert & Ziegler supports new radiopharmaceuticals
By AuntMinnieEurope.com staff writers
Isotope technology developer Eckert & Ziegler has agreed to provide financial backing for the development of two new radiopharmaceuticals for diagnosing and treating lymphoma.
March 3, 2020
2016 08 24 09 43 13 537 Hands Shaking V3 400
RCR posts clinical, interventional radiology curricula
By AuntMinnieEurope.com staff writers
The U.K. Royal College of Radiologists (RCR) has published new curricula for clinical and interventional radiology.
February 18, 2020
2020 02 19 17 47 3684 Doctors Residents Student Education 400
Isotopia, Eckert & Ziegler partner
By AuntMinnieEurope.com staff writers
Isotopia Molecular Imaging has partnered with isotope technology firm Eckert & Ziegler for the development of its PSMA-11 kit for prostate cancer imaging.
February 16, 2020
2019 11 11 22 17 5854 Arrows Join Partner 400
PentixaPharm gets 15M euros for radiopharmaceutical trials
By AuntMinnieEurope.com staff writers
PentixaPharm has announced 15 million euros in funding to test a pair of radiopharmaceutical drugs to identify fast-progressing diseases, including cancer.
February 6, 2020
2019 07 04 00 21 3668 Euros Bills 400
Week in Review: Radiologist struck off for lying | Italy presents plan for ethical AI | Why do women miss breast screening?
By Philip Ward
February 6, 2020
EANM offers prostate cancer care prerequisites
By AuntMinnieEurope.com staff writers
The European Association of Nuclear Medicine (EANM) is among the contributors to a guide for oncology care providers, patient groups, policymakers, and managers on what healthcare systems need to provide high-quality prostate cancer care.
February 4, 2020
2019 05 03 20 23 2154 Prostate 3 D 400
Previous Page
Page 18 of 90
Next Page